EUVIMEDObjevte EUVIMED
StudienprotokollOpen access

Healthy Trust and Pandemic Readiness in the Context of Messenger RNA Vaccines: Protocol for a Sequential Deliberative Dialogue Study

Katrina Plamondon, Rodrigo Curty Pereira, Angeli Rawat

JMIR Research Protocols · 2026-09-25 · 15 · e91534-e91534

DOI: 10.2196/91534 ↗

At a glance

Studienprotokoll in JMIR Research Protocols, published online on 2026-09-25. Written by Katrina Plamondon and 2 co-authors. Institution: School of Nursing, Faculty of Health and Social Development, University of British Columbia, Okanagan Campus, Landmark 4 Bldg, 6th Fl, 1628 Dickson A…. Major MEDLINE topics: Trust, COVID-19, Pandemics, COVID-19 Vaccines. 87 references. The full text is freely available in PubMed Central.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Pandemics threaten economies, security, and public health, requiring strong global and local collaboration and coordination. Public receptivity to emergent vaccine technologies is essential to pandemic readiness. Although messenger RNA (mRNA) vaccines offer rapid adaptability and hold promise, their use during the COVID-19 pandemic was met with polarizing debates that raise questions about the conditions needed to support acceptable and equitable use of new vaccines.

Objective

This deliberative dialogue study aims to generate consensus on how to ensure informed, accessible public engagement and strengthen public trust in a climate of divisiveness and misinformation, disinformation, and malinformation. Using mRNA vaccines as a case study, the project’s specific research objective is to seek insights into what people believe is needed for public understanding, equitable access, and acceptance of emerging vaccine technologies.

Methods

Using a sequential deliberative dialogue design, this study invites individuals with significant influence on pandemic readiness and those most likely to be disproportionately affected by related decisions into reflective, conversational, workshop-style online events and self-led dialogues. Dialogues and guiding questions are informed by a knowledge synthesis on what is unknown about mRNA vaccine public sentiments based on a rapid review, an environmental scan, consultations with experts across sectors, and ongoing updates from the dialogues. Data will be analyzed in situ in an iterative and collaborative synthesis of general agreements between dialogue contributors in response to guiding questions and emerging themes. Dialogue reports will be drafted by the research team based on observational notes, transcripts, and video recordings and reviewed by contributors. In summative dialogues, the research team will present main threads of dialogue, responding to research objectives and newly identified knowledge gaps and collecting input to inform dialogue outputs.

Results

This study was funded in May 2025. As of June 2026, we have conducted 10 deliberative dialogues and supported 1 self-led dialogue, engaging 77 contributors across sectors and disciplines. We held 2 summative dialogues with 18 attendees, where we presented the main threads of dialogue as identified by the research team through collaborative analysis. We have started incorporating input from closing dialogues into the final reports and expect to publish the results in the second half of 2026, both as lay-language reports and peer-reviewed manuscripts.

Conclusions

This protocol outlines a consensus-building process capable of deepening the understanding of vaccine hesitancy and strengthening pandemic readiness and public trust in Canada. Dialogues are expected to provide general agreements on how to enhance science and health literacy, tailor communications considering historical inequities, respond to the needs of health care workers, and navigate polarization around vaccination. By creating space for shared learning and collective insight, this study supports the rebuilding of trust in public health institutions as they adapt to evolving societal expectations.

Subjects

MeSH terms (MEDLINE)

TrustCOVID-19PandemicsCOVID-19 VaccinesmRNA VaccinesHumansPandemic PreparednessSARS-CoV-2Communication

Author keywords

deliberative dialoguesimmunizationmRNA vaccinespandemic readinesstrustvaccine hesitancy

Substances

COVID-19 VaccinesmRNA Vaccines

Authors and institutions

  • School of Nursing, Faculty of Health and Social Development, University of British Columbia, Okanagan Campus, Landmark 4 Bldg, 6th Fl, 1628 Dickson Avenue, Kelowna, BC, BC, V1Y 5Y7, Canada, 1 250-807-8681.

Cite

APA

Plamondon, K., Curty Pereira, R., & Rawat, A. (2026). Healthy Trust and Pandemic Readiness in the Context of Messenger RNA Vaccines: Protocol for a Sequential Deliberative Dialogue Study. JMIR Research Protocols, 15, e91534-e91534. https://doi.org/10.2196/91534

Vancouver

Plamondon K, Curty Pereira R, Rawat A. Healthy Trust and Pandemic Readiness in the Context of Messenger RNA Vaccines: Protocol for a Sequential Deliberative Dialogue Study. JMIR Research Protocols. 2026;15:e91534-e91534. doi:10.2196/91534

BibTeX
@article{Plamondon2026,
  author = {Plamondon, Katrina and Curty Pereira, Rodrigo and Rawat, Angeli},
  title = {Healthy Trust and Pandemic Readiness in the Context of Messenger RNA Vaccines: Protocol for a Sequential Deliberative Dialogue Study},
  journal = {JMIR Research Protocols},
  year = {2026},
  volume = {15},
  pages = {e91534--e91534},
  doi = {10.2196/91534}
}
Start for free →